Artia Global Partners »

Ascendis Pharma A S shares owned by Artia Global Partners

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.0M 7.4k 136.38
2024-03-31 $2.4M 16k 151.17

More positions owned by Artia Global Partners

Novo-nordisk A S Adr (NVO)
Eli Lilly & Co. (LLY)
Lilly Eli & Co option Put Option
Merck & Co (MRK)
Novo-nordisk A S Adr Put Option
Viking Therapeutics (VKTX)
Astrazeneca Sponsored Adr (AZN)
Intra Cellular Therapies (ITCI)
Vertex Pharmaceuticals Incorporated (VRTX)
Alnylam Pharmaceuticals (ALNY)
Viking Therapeutics Inc call Call Option
Insmed Com Par $.01 Put Option
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)

View all positions for Artia Global Partners

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
FMR
Artisan Partners Limited Partnership
venBio Select Advisor
Henderson Group
Wellington Management Company
Capital Research and Management Company - Division 3
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Invesco
Vestal Point Capital
Sofinnova Ventures
Paradigm Biocapital Advisors

View all funds holding Ascendis Pharma A S